Chronic Myeloid Leukemia (CML) is characterized by the presence of a translocation between chromosomes 9 and 22 in the hematopoietic stem cell, leading to the expression of the chimeric protein BCR-ABL. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.